Get startedLog in
    Picture of Extrawell Pharmaceutical Holdings logo

    858 — Extrawell Pharmaceutical Holdings Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Extrawell Pharmaceutical Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line85.5-120132131-160
    Depreciation
    Non-Cash Items-91.1110-145-141153
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-13.91.032.122.95-6.55
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Other Operating Cash Flow
    Cash from Operating Activities-13.3-0.852-1.771.18-3.69
    Capital Expenditures-0.162-0.721-9.63-6.62-1.2
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-7.140.6770.252-1.823.24
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-7.3-0.044-9.38-8.442.04
    Financing Cash Flow Items-0.033-0.212-0.135-0.092-0.294
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-0.241-1.9-1.94-2.39-6.5
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-22.50.273-14.8-9.48-8.79